这是一篇来自已证抗体库的有关人类 IL-17 (IL-17) 的综述,是根据129篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IL-17 抗体。
IL-17 同义词: CTLA-8; CTLA8; IL-17; IL-17A; IL17; interleukin-17A; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)

赛默飞世尔
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 s3c
赛默飞世尔IL-17抗体(eBiosciences, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 s3c). Int J Hematol (2018) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔IL-17抗体(Thermo Fisher Scientific, 12-7178-41)被用于被用于流式细胞仪在人类样本上 (图 3b). J Clin Invest (2018) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 图 s4c
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在人类样本上 (图 s4c). J Clin Invest (2018) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 1:100; 图 5h
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 5h). Nat Commun (2018) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, 11-7179)被用于被用于流式细胞仪在人类样本上. J Immunol (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 羊; 图 4b
  • 流式细胞仪; 牛; 图 4b
赛默飞世尔IL-17抗体(eBiosciences, 12-7179-41)被用于被用于流式细胞仪在羊样本上 (图 4b) 和 被用于流式细胞仪在牛样本上 (图 4b). Vet Res (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 4b). J Immunol (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔IL-17抗体(eBiosciences, eBio64-DEC17)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 6a
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 6a). Immunity (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 5a
赛默飞世尔IL-17抗体(Ebiosciences, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 5a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔IL-17抗体(eBioscience, 11-7179-41)被用于被用于流式细胞仪在人类样本上 (图 3b). Mol Med Rep (2017) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 4c
赛默飞世尔IL-17抗体(eBioscience, 17-7179-42)被用于被用于流式细胞仪在人类样本上 (图 4c). Front Immunol (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 猕猴; 图 6c
赛默飞世尔IL-17抗体(eBioscience, 12-7178-41)被用于被用于流式细胞仪在猕猴样本上 (图 6c). Transplantation (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 2). PLoS Pathog (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-17抗体(eBiosciences, eBio64CAP17)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 酶联免疫吸附测定; 人类; 图 1
赛默飞世尔IL-17抗体(eBiosciences, eBio64DEC17)被用于被用于酶联免疫吸附测定在人类样本上 (图 1). Arthritis Res Ther (2016) ncbi
小鼠 单克隆(eBio64DEC17)
赛默飞世尔IL-17抗体(eBioscience, 25-7179-42)被用于. Nat Med (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; African green monkey; 图 1e
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在African green monkey样本上 (图 1e). J Med Primatol (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 2e
赛默飞世尔IL-17抗体(eBiosciences, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 2e). JCI Insight (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 1:100; 图 2b
赛默飞世尔IL-17抗体(eBiosciences, 12-7178)被用于被用于流式细胞仪在人类样本上浓度为1:100 (图 2b). Mol Med Rep (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 猕猴; 图 1b
赛默飞世尔IL-17抗体(eBiosciences, eBio64CAP17)被用于被用于流式细胞仪在猕猴样本上 (图 1b). J Immunol (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 5f
赛默飞世尔IL-17抗体(eBiosciences, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 5f). J Leukoc Biol (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 1:10; 表 2
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17b)被用于被用于流式细胞仪在人类样本上浓度为1:10 (表 2). Vet Parasitol (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3f
赛默飞世尔IL-17抗体(eBiosciences, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 3f). PLoS ONE (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔IL-17抗体(eBioscience, 17-7179-42)被用于被用于流式细胞仪在人类样本上 (图 3). Mediators Inflamm (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔IL-17抗体(eBioscience, 64DEC17)被用于被用于流式细胞仪在人类样本上 (图 7). Retrovirology (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 7). Haematologica (2016) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-17抗体(eBioscience, 14-7178-85)被用于被用于流式细胞仪在人类样本上 (图 2). Allergy (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔IL-17抗体(eBioscience, 53-7179)被用于被用于流式细胞仪在人类样本上 (图 3). Allergy (2016) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔IL-17抗体(eBioscience, 12-7179)被用于被用于流式细胞仪在人类样本上 (图 1). Stem Cell Reports (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3b
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 3b). Kidney Int (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, clone eBio64DEC17)被用于被用于流式细胞仪在人类样本上. Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(Ebioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. Clin Immunol (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, 17-7179-42)被用于被用于流式细胞仪在人类样本上. Scand J Immunol (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 表 s5
赛默飞世尔IL-17抗体(eBioscience, 64DEC17)被用于被用于流式细胞仪在人类样本上 (表 s5). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, . 53-7179-41)被用于被用于流式细胞仪在人类样本上. Curr Protoc Cytom (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. Immun Inflamm Dis (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. Chest (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, EBIO64CAP17)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(eBio64CAP17)
  • 酶联免疫吸附测定; 人类; 1:1000
赛默飞世尔IL-17抗体(eBioscience, eBio64cap17)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:1000. Nat Commun (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 酶联免疫吸附测定; 人类; 1:1000
赛默飞世尔IL-17抗体(eBioscience, eBio64dec17)被用于被用于酶联免疫吸附测定在人类样本上浓度为1:1000. Nat Commun (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在人类样本上. Vaccine (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔IL-17抗体(eBioscience, eBio64dec17)被用于被用于流式细胞仪在人类样本上 (图 1). Immunology (2015) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, ebio64Dec17)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上. J Cell Physiol (2014) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 图 1d
赛默飞世尔IL-17抗体(eBiosciences, eBio64CAP17)被用于被用于流式细胞仪在人类样本上 (图 1d). J Infect Dis (2014) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 2). Ann Rheum Dis (2014) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; African green monkey; 图 s1c
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在African green monkey样本上 (图 s1c). J Immunol (2013) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, eBIO64CAP17)被用于被用于流式细胞仪在人类样本上. Tuberculosis (Edinb) (2013) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 1:50; 图 1
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1). PLoS ONE (2012) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 猕猴
  • 免疫组化; 猕猴
赛默飞世尔IL-17抗体(eBioscience, eBio64CAP17)被用于被用于流式细胞仪在猕猴样本上 和 被用于免疫组化在猕猴样本上. Mucosal Immunol (2012) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 3). Immunology (2010) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类
赛默飞世尔IL-17抗体(eBioscience, 64CAP17)被用于被用于流式细胞仪在人类样本上. Arthritis Rheum (2010) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔IL-17抗体(eBioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2009) ncbi
小鼠 单克隆(eBio64CAP17)
  • 流式细胞仪; 人类; 图 4a
赛默飞世尔IL-17抗体(eBioscience, 6CAP17)被用于被用于流式细胞仪在人类样本上 (图 4a). Blood (2008) ncbi
小鼠 单克隆(eBio64DEC17)
  • 流式细胞仪; 人类; 图 1A
赛默飞世尔IL-17抗体(e-Bioscience, eBio64DEC17)被用于被用于流式细胞仪在人类样本上 (图 1A). Ann Rheum Dis (2008) ncbi
BioLegend
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 1:50; 图 s10c
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 s10c). Nature (2019) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 3a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 3a). Front Immunol (2018) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 猕猴; 图 1a
BioLegendIL-17抗体(BioLegend, 512307)被用于被用于流式细胞仪在猕猴样本上 (图 1a). Cell (2018) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 s1a
BioLegendIL-17抗体(biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2017) ncbi
小鼠 单克隆(BL168)
  • mass cytometry; 人类; 图 2a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于mass cytometry在人类样本上 (图 2a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 1a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 1a). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 3d
BioLegendIL-17抗体(BioLegend, 512304)被用于被用于流式细胞仪在人类样本上 (图 3d). J Clin Invest (2017) ncbi
小鼠 单克隆(BL168)
  • 免疫组化-石蜡切片; 人类; 图 7
  • 流式细胞仪; 人类; 图 4a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于免疫组化-石蜡切片在人类样本上 (图 7) 和 被用于流式细胞仪在人类样本上 (图 4a). PLoS ONE (2017) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 5a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 5a). J Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 表 1
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (表 1). Cytometry A (2017) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 3a
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 3a). Int J Cancer (2017) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 6a
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 6a). Clin Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 s1c
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 s1c). Eur J Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 3a
BioLegendIL-17抗体(biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 2a
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 2a). PLoS Pathog (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; African green monkey; 图 1
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在African green monkey样本上 (图 1). J Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 4c
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 4c). PLoS ONE (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 s2a
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 s2a). J Immunol (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 6i
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 6i). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 1:200; 图 6
BioLegendIL-17抗体(Biolegend, BL168;)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 6). Nat Commun (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类
BioLegendIL-17抗体(BioLegend, 512305)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类
BioLegendIL-17抗体(Biolegend, Clone BL168)被用于被用于流式细胞仪在人类样本上. Int J Infect Dis (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 2 ul/test
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上浓度为2 ul/test. J Immunol Methods (2015) ncbi
小鼠 单克隆(BL23)
  • dot blot; 人类; 表 s1
BioLegendIL-17抗体(Biolegend, 512702)被用于被用于dot blot在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 1
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 1). J Autoimmun (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 4
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 4). Nat Immunol (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上. Nat Immunol (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 1:20
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在人类样本上浓度为1:20. Nat Med (2014) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2014) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 2
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 2). J Infect Dis (2015) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 小鼠; 1:50
BioLegendIL-17抗体(BioLegend, BL168)被用于被用于流式细胞仪在小鼠样本上浓度为1:50. Nat Commun (2014) ncbi
小鼠 单克隆(BL168)
  • 流式细胞仪; 人类; 图 5a
BioLegendIL-17抗体(Biolegend, BL168)被用于被用于流式细胞仪在人类样本上 (图 5a). J Invest Dermatol (2015) ncbi
安迪生物R&D
小鼠 单克隆(41802)
  • 流式细胞仪; 猕猴; 图 5b
安迪生物R&DIL-17抗体(R&D Systems, 41802)被用于被用于流式细胞仪在猕猴样本上 (图 5b). JCI Insight (2017) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 3.5 ug/ml; 表 2
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上浓度为3.5 ug/ml (表 2). Pathology (2016) ncbi
山羊 多克隆
  • 免疫组化; 人类; 1:100; 图 6h
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化在人类样本上浓度为1:100 (图 6h). JCI Insight (2016) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 表 1
安迪生物R&DIL-17抗体(R n D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 1). J Oral Pathol Med (2017) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 图 1a
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1a). Nat Med (2015) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 1:50; 图 6
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 6). BMC Surg (2015) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 图 3
安迪生物R&DIL-17抗体(RD systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3). Scand J Immunol (2015) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上. Cancer Immunol Immunother (2015) ncbi
安迪生物R&DIL-17抗体(R&D System, D1700)被用于. Immunobiology (2015) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 1:40
安迪生物R&DIL-17抗体(R&D Systems, AF--317- NA)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:40. J Eur Acad Dermatol Venereol (2015) ncbi
山羊 多克隆
  • 免疫印迹; 人类
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫印迹在人类样本上. J Invest Dermatol (2015) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类
安迪生物R&DIL-17抗体(R&D, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上. Arch Dermatol Res (2014) ncbi
山羊 多克隆
  • 免疫组化-石蜡切片; 人类; 图 2
安迪生物R&DIL-17抗体(R&D Systems, AF-317-NA)被用于被用于免疫组化-石蜡切片在人类样本上 (图 2). Rheumatology (Oxford) (2014) ncbi
MABTECH
小鼠 单克隆(MT44.6)
  • 流式细胞仪; 羊; 图 4c
  • 流式细胞仪; 牛; 图 4c
MABTECHIL-17抗体(Mabtech, 3520-3-250)被用于被用于流式细胞仪在羊样本上 (图 4c) 和 被用于流式细胞仪在牛样本上 (图 4c). Vet Res (2017) ncbi
小鼠 单克隆(MT241)
  • 流式细胞仪; 牛; 图 4c
  • 流式细胞仪; 羊; 图 4c
MABTECHIL-17抗体(Mabtech, 3520M-3-250)被用于被用于流式细胞仪在牛样本上 (图 4c) 和 被用于流式细胞仪在羊样本上 (图 4c). Vet Res (2017) ncbi
小鼠 单克隆(MT504)
  • 流式细胞仪; 牛; 图 4c
  • 流式细胞仪; 羊; 图 4c
MABTECHIL-17抗体(Mabtech, 3520-6-250)被用于被用于流式细胞仪在牛样本上 (图 4c) 和 被用于流式细胞仪在羊样本上 (图 4c). Vet Res (2017) ncbi
艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫组化-冰冻切片; 人类; 图 2b
艾博抗(上海)贸易有限公司IL-17抗体(Abcam, ab79056)被用于被用于免疫组化-冰冻切片在人类样本上 (图 2b). J Clin Invest (2017) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 图 4
艾博抗(上海)贸易有限公司IL-17抗体(Abcam, ab79056)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). Arthritis Res Ther (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 图 1
艾博抗(上海)贸易有限公司IL-17抗体(Abcam, ab79056)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). Oncotarget (2016) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 5 ug/ml; 图 3a
  • 免疫印迹; 人类; 图 3e
艾博抗(上海)贸易有限公司IL-17抗体(abcam, ab136668)被用于被用于免疫组化-石蜡切片在人类样本上浓度为5 ug/ml (图 3a) 和 被用于免疫印迹在人类样本上 (图 3e). PLoS ONE (2015) ncbi
兔 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:50; 图 s5
艾博抗(上海)贸易有限公司IL-17抗体(Abcam, ab79056)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:50 (图 s5). Nat Commun (2015) ncbi
兔 多克隆
艾博抗(上海)贸易有限公司IL-17抗体(Abcam, 9565)被用于. Cytokine (2014) ncbi
LifeSpan Biosciences
小鼠 单克隆(4k5f6)
  • 免疫组化-石蜡切片; 人类; 7 ug/ml; 图 4
  • 免疫组化; 人类
LifeSpan BiosciencesIL-17抗体(LifeSpan BioSciences, LS-B8323)被用于被用于免疫组化-石蜡切片在人类样本上浓度为7 ug/ml (图 4) 和 被用于免疫组化在人类样本上. PLoS ONE (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆(G-4)
  • 免疫印迹; 大鼠; 图 5
圣克鲁斯生物技术IL-17抗体(Santa Cruz, sc-374218)被用于被用于免疫印迹在大鼠样本上 (图 5). Mol Med Rep (2016) ncbi
武汉三鹰
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100
武汉三鹰IL-17抗体(Proteintech, 13082-1-AP)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. PLoS ONE (2014) ncbi
碧迪BD
单克隆(TC11-18H10)
  • 流式细胞仪; 小鼠; 图 s3e
碧迪BDIL-17抗体(BD, 566286)被用于被用于流式细胞仪在小鼠样本上 (图 s3e). Cell (2018) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 1
碧迪BDIL-17抗体(BD Biosciences, 560486)被用于被用于流式细胞仪在人类样本上 (图 1). Exp Ther Med (2017) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 4a
碧迪BDIL-17抗体(BD Biosciences, N49-653)被用于被用于流式细胞仪在人类样本上 (图 4a). J Immunol (2017) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 1a
碧迪BDIL-17抗体(BD, N49-653)被用于被用于流式细胞仪在人类样本上 (图 1a). Tuberculosis (Edinb) (2016) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 1c
碧迪BDIL-17抗体(BD Biosciences, N49-653)被用于被用于流式细胞仪在人类样本上 (图 1c). Oncotarget (2016) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 小鼠; 图 1a
碧迪BDIL-17抗体(BD Biosciences, N49.653)被用于被用于流式细胞仪在小鼠样本上 (图 1a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 s1b
碧迪BDIL-17抗体(BD, N49-653)被用于被用于流式细胞仪在人类样本上 (图 s1b). J Immunol (2016) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 小鼠; 图 2
碧迪BDIL-17抗体(BD Pharmingen, 560438)被用于被用于流式细胞仪在小鼠样本上 (图 2). PLoS Pathog (2016) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 2b
碧迪BDIL-17抗体(BD Biosciences, N49-653)被用于被用于流式细胞仪在人类样本上 (图 2b). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 人类; 图 2c
碧迪BDIL-17抗体(BD PharMingen, 560436)被用于被用于流式细胞仪在人类样本上 (图 2c). PLoS ONE (2015) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 4
碧迪BDIL-17抗体(BD Biosciences, N49-653)被用于被用于流式细胞仪在人类样本上 (图 4). Mucosal Immunol (2016) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 人类; 1:50; 图 1
碧迪BDIL-17抗体(BD, 560439)被用于被用于流式细胞仪在人类样本上浓度为1:50 (图 1). Clin Vaccine Immunol (2015) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 4:100; 图 3a
碧迪BDIL-17抗体(Becton Dickinson, N49-653)被用于被用于流式细胞仪在人类样本上浓度为4:100 (图 3a). Nat Commun (2015) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 2b
碧迪BDIL-17抗体(BD Biosciences, N49-653)被用于被用于流式细胞仪在人类样本上 (图 2b). J Immunol (2015) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 人类; 图 4
碧迪BDIL-17抗体(BD Pharmingen, SCPL1362)被用于被用于流式细胞仪在人类样本上 (图 4). Stem Cell Res Ther (2015) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类; 图 1d
碧迪BDIL-17抗体(BD Bioscience, 560799)被用于被用于流式细胞仪在人类样本上 (图 1d). Immunol Res (2015) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 猪
碧迪BDIL-17抗体(BD Biosciences, SCPL1362)被用于被用于流式细胞仪在猪样本上. Mol Immunol (2015) ncbi
小鼠 单克隆(SCPL1362)
  • 流式细胞仪; 人类; 图 3a
碧迪BDIL-17抗体(BD Biosciences, 560436)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncotarget (2014) ncbi
小鼠 单克隆(N49-653)
  • 流式细胞仪; 人类
碧迪BDIL-17抗体(BD, N49-653)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
文章列表
  1. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed 出版商
  2. Grohmann M, Wiede F, Dodd G, Gurzov E, Ooi G, Butt T, et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC. Cell. 2018;175:1289-1306.e20 pubmed 出版商
  3. Watanabe N, Takaku T, Takeda K, Shirane S, Toyota T, Koike M, et al. Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients. Int J Hematol. 2018;108:588-597 pubmed 出版商
  4. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed 出版商
  5. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed 出版商
  6. Provine N, Binder B, FitzPatrick M, Schuch A, Garner L, Williamson K, et al. Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells. Front Immunol. 2018;9:756 pubmed 出版商
  7. Hsieh W, Hsu T, Chang Y, Lai M. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells. Nat Commun. 2018;9:463 pubmed 出版商
  8. Linehan J, Harrison O, Han S, Byrd A, Vujkovic Cvijin I, Villarino A, et al. Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair. Cell. 2018;172:784-796.e18 pubmed 出版商
  9. Matos T, O Malley J, Lowry E, Hamm D, Kirsch I, Robins H, et al. Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing ?? T cell clones. J Clin Invest. 2017;127:4031-4041 pubmed 出版商
  10. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed 出版商
  11. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed 出版商
  12. Dias J, Leeansyah E, Sandberg J. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. Proc Natl Acad Sci U S A. 2017;114:E5434-E5443 pubmed 出版商
  13. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed 出版商
  14. Lu G, Zhang X, Shen L, Qiao Q, Li Y, Sun J, et al. CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy. PLoS ONE. 2017;12:e0178352 pubmed 出版商
  15. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed 出版商
  16. Zanin Zhorov A, Weiss J, Trzeciak A, Chen W, Zhang J, Nyuydzefe M, et al. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. J Immunol. 2017;198:3809-3814 pubmed 出版商
  17. Wattegedera S, Corripio Miyar Y, Pang Y, Frew D, McNeilly T, Palarea Albaladejo J, et al. Enhancing the toolbox to study IL-17A in cattle and sheep. Vet Res. 2017;48:20 pubmed 出版商
  18. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed 出版商
  19. Tyler C, McCarthy N, Lindsay J, Stagg A, Moser B, Eberl M. Antigen-Presenting Human γδ T Cells Promote Intestinal CD4+ T Cell Expression of IL-22 and Mucosal Release of Calprotectin. J Immunol. 2017;198:3417-3425 pubmed 出版商
  20. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed 出版商
  21. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed 出版商
  22. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed 出版商
  23. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed 出版商
  24. Yang Y, Wang Q, Xie M, Liu P, Qi X, Liu X, et al. Berberine exerts an anti-inflammatory role in ocular Behcet's disease. Mol Med Rep. 2017;15:97-102 pubmed 出版商
  25. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  26. Riou C, Bunjun R, Müller T, Kiravu A, Ginbot Z, Oni T, et al. Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection. Tuberculosis (Edinb). 2016;101:25-30 pubmed 出版商
  27. Hippen K, Watkins B, Tkachev V, Lemire A, Lehnen C, Riddle M, et al. Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease. Transplantation. 2016;100:2630-2639 pubmed 出版商
  28. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  29. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed 出版商
  30. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed 出版商
  31. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed 出版商
  32. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed 出版商
  33. Javvadi L, Parachuru V, Milne T, Seymour G, Rich A. Regulatory T-cells and IL17A(+) cells infiltrate oral lichen planus lesions. Pathology. 2016;48:564-73 pubmed 出版商
  34. Chuang H, Chen Y, Hung W, Li J, Chen D, Lan J, et al. Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis. Oncotarget. 2016;7:57593-57605 pubmed 出版商
  35. Ulges A, Witsch E, Pramanik G, Klein M, Birkner K, Bühler U, et al. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development. Proc Natl Acad Sci U S A. 2016;113:10145-50 pubmed 出版商
  36. Dahal L, Basu N, Youssef H, Khanolkar R, Barker R, Erwig L, et al. Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:180 pubmed 出版商
  37. Deléage C, Schuetz A, Alvord W, Johnston L, Hao X, Morcock D, et al. Impact of early cART in the gut during acute HIV infection. JCI Insight. 2016;1: pubmed
  38. Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, et al. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses. J Immunol. 2016;197:1100-1110 pubmed 出版商
  39. Chukkapalli S, Rivera Kweh M, Gehlot P, Velsko I, Bhattacharyya I, Calise S, et al. Periodontal bacterial colonization in synovial tissues exacerbates collagen-induced arthritis in B10.RIII mice. Arthritis Res Ther. 2016;18:161 pubmed 出版商
  40. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed 出版商
  41. Avadhani A, Parachuru V, Milne T, Seymour G, Rich A. Multiple cells express interleukin 17 in oral squamous cell carcinoma. J Oral Pathol Med. 2017;46:39-45 pubmed 出版商
  42. Wang T, Pan D, Zhou Z, You Y, Jiang C, Zhao X, et al. Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. PLoS Pathog. 2016;12:e1005662 pubmed 出版商
  43. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed 出版商
  44. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed 出版商
  45. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed 出版商
  46. Roth S, Spalinger M, Gottier C, Biedermann L, Zeitz J, Lang S, et al. Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis. PLoS ONE. 2016;11:e0154817 pubmed 出版商
  47. Fu D, Song X, Hu H, Sun M, Li Z, Tian Z. Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis. Mol Med Rep. 2016;13:4606-12 pubmed 出版商
  48. Li M, Chen X, Liu J, Wang D, Gan L, Lv X, et al. Treatment of experimental autoimmune uveoretinitis with different natural compounds. Mol Med Rep. 2016;13:4654-8 pubmed 出版商
  49. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed 出版商
  50. Taylor P, Roy S, Meszaros E, Sun Y, Howell S, Malemud C, et al. JAK/STAT regulation of Aspergillus fumigatus corneal infections and IL-6/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity. J Leukoc Biol. 2016;100:213-22 pubmed 出版商
  51. Chen C, Liu Y, Hua M, Li X, Ji C, Ma D. Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia. Oncotarget. 2016;7:24455-65 pubmed 出版商
  52. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed 出版商
  53. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed 出版商
  54. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed 出版商
  55. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed 出版商
  56. Di Meglio P, Villanova F, Navarini A, Mylonas A, Tosi I, Nestle F, et al. Targeting CD8(+) T cells prevents psoriasis development. J Allergy Clin Immunol. 2016;138:274-276.e6 pubmed 出版商
  57. Vargas Inchaustegui D, Demers A, Shaw J, Kang G, Ball D, Tuero I, et al. Vaccine Induction of Lymph Node-Resident Simian Immunodeficiency Virus Env-Specific T Follicular Helper Cells in Rhesus Macaques. J Immunol. 2016;196:1700-10 pubmed 出版商
  58. Bjerg Christensen A, Dige A, Vad Nielsen J, Brinkmann C, Bendix M, Østergaard L, et al. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators Inflamm. 2015;2015:120605 pubmed 出版商
  59. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed 出版商
  60. Cleret Buhot A, Zhang Y, Planas D, Goulet J, Monteiro P, Gosselin A, et al. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology. 2015;12:102 pubmed 出版商
  61. Alam M, Gaida M, Bergmann F, Lasitschka F, Giese T, Giese N, et al. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression. Nat Med. 2015;21:1337-43 pubmed 出版商
  62. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed 出版商
  63. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  64. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  65. Wawrzyniak M, Ochsner U, Wirz O, Wawrzyniak P, Van De Veen W, Akdis C, et al. A novel, dual cytokine-secretion assay for the purification of human Th22 cells that do not co-produce IL-17A. Allergy. 2016;71:47-57 pubmed 出版商
  66. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed 出版商
  67. Wang W, Yen M, Liu K, Hsu P, Lin M, Chen P, et al. Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses. Stem Cell Reports. 2015;5:392-404 pubmed 出版商
  68. Leeansyah E, Svärd J, Dias J, Buggert M, Nyström J, Quigley M, et al. Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection. PLoS Pathog. 2015;11:e1005072 pubmed 出版商
  69. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed 出版商
  70. Yoon J, Sudo K, Kuroda M, Kato M, Lee I, Han J, et al. Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation. Nat Commun. 2015;6:7600 pubmed 出版商
  71. Adoro S, Cubillos Ruiz J, Chen X, Deruaz M, Vrbanac V, Song M, et al. IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection. Nat Commun. 2015;6:7562 pubmed 出版商
  72. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed 出版商
  73. Patel N, Gallagher J, Torgerson T, Gilman A. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome. J Clin Immunol. 2015;35:479-85 pubmed 出版商
  74. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed 出版商
  75. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed 出版商
  76. Brunner S, Weber F, Werner J, Agha A, Farkas S, Schlitt H, et al. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification. BMC Surg. 2015;15:49 pubmed 出版商
  77. Lenz N, Schindler T, Kagina B, Zhang J, Lukindo T, Mpina M, et al. Antiviral Innate Immune Activation in HIV-Infected Adults Negatively Affects H1/IC31-Induced Vaccine-Specific Memory CD4+ T Cells. Clin Vaccine Immunol. 2015;22:688-96 pubmed 出版商
  78. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed 出版商
  79. Axelsson Robertson R, Ju J, Kim H, Zumla A, Maeurer M. Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis. Int J Infect Dis. 2015;32:13-22 pubmed 出版商
  80. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed 出版商
  81. Punt S, van Vliet M, Spaans V, de Kroon C, Fleuren G, Gorter A, et al. FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma. Cancer Immunol Immunother. 2015;64:745-53 pubmed 出版商
  82. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed 出版商
  83. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed 出版商
  84. Vocca L, Di Sano C, Uasuf C, Sala A, Riccobono L, Gangemi S, et al. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology. 2015;220:954-63 pubmed 出版商
  85. Lu Y, Xue Q, Eisele M, Sulistijo E, Brower K, Han L, et al. Highly multiplexed profiling of single-cell effector functions reveals deep functional heterogeneity in response to pathogenic ligands. Proc Natl Acad Sci U S A. 2015;112:E607-15 pubmed 出版商
  86. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed 出版商
  87. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed 出版商
  88. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed 出版商
  89. Karlsson F, Hassan Zahraee M. Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation. Curr Protoc Cytom. 2015;71:6.35.1-7 pubmed 出版商
  90. Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, et al. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4+ T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61:269-80 pubmed 出版商
  91. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed 出版商
  92. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed 出版商
  93. Gerner W, Talker S, Koinig H, Sedlak C, Mair K, Saalmüller A. Phenotypic and functional differentiation of porcine αβ T cells: current knowledge and available tools. Mol Immunol. 2015;66:3-13 pubmed 出版商
  94. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  95. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed 出版商
  96. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  97. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed 出版商
  98. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed 出版商
  99. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed 出版商
  100. Batista D, Perez L, Orfali R, Zaniboni M, Samorano L, Pereira N, et al. Profile of skin barrier proteins (filaggrin, claudins 1 and 4) and Th1/Th2/Th17 cytokines in adults with atopic dermatitis. J Eur Acad Dermatol Venereol. 2015;29:1091-5 pubmed 出版商
  101. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed 出版商
  102. Gibbons D, Fleming P, Virasami A, Michel M, Sebire N, Costeloe K, et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat Med. 2014;20:1206-10 pubmed 出版商
  103. Kagina B, Tameris M, Geldenhuys H, Hatherill M, Abel B, Hussey G, et al. The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses. Vaccine. 2014;32:5908-17 pubmed 出版商
  104. Wu N, Huang D, Tsou H, Lin Y, Lin W. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. J Invest Dermatol. 2015;135:490-498 pubmed 出版商
  105. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed 出版商
  106. Tchakoute C, Hesseling A, Kidzeru E, Gamieldien H, Passmore J, Jones C, et al. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants. J Infect Dis. 2015;211:338-46 pubmed 出版商
  107. Chuang H, Sheu W, Lin Y, Tsai C, Yang C, Cheng Y, et al. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nat Commun. 2014;5:4602 pubmed 出版商
  108. Kakeda M, Schlapbach C, Danelon G, Tang M, Cecchinato V, Yawalkar N, et al. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis. Arch Dermatol Res. 2014;306:933-8 pubmed 出版商
  109. Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients. J Invest Dermatol. 2015;135:110-118 pubmed 出版商
  110. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  111. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed 出版商
  112. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed 出版商
  113. Staumont Sallé D, Fleury S, Lazzari A, Molendi Coste O, Hornez N, Lavogiez C, et al. CX?CL1 (fractalkine) and its receptor CX?CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. J Exp Med. 2014;211:1185-96 pubmed 出版商
  114. Ardeljan D, Wang Y, Park S, Shen D, Chu X, Yu C, et al. Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS ONE. 2014;9:e95900 pubmed 出版商
  115. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  116. Galindo Albarrán A, Ramirez Pliego O, Labastida Conde R, Melchy Pérez E, Liquitaya Montiel A, Esquivel Guadarrama F, et al. CD43 signals prepare human T cells to receive cytokine differentiation signals. J Cell Physiol. 2014;229:172-80 pubmed
  117. Harvey B, Sia T, Wattchow D, Smid S. Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. Cytokine. 2014;65:236-44 pubmed 出版商
  118. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed 出版商
  119. Kouri V, Olkkonen J, Ainola M, Li T, Björkman L, Konttinen Y, et al. Neutrophils produce interleukin-17B in rheumatoid synovial tissue. Rheumatology (Oxford). 2014;53:39-47 pubmed 出版商
  120. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商
  121. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed 出版商
  122. Marin N, Paris S, Rojas M, Garcia L. Functional profile of CD4+ and CD8+ T cells in latently infected individuals and patients with active TB. Tuberculosis (Edinb). 2013;93:155-66 pubmed 出版商
  123. Wolff M, Leung J, Davenport M, Poles M, Cho I, Loke P. TH17, TH22 and Treg cells are enriched in the healthy human cecum. PLoS ONE. 2012;7:e41373 pubmed 出版商
  124. Klatt N, Estes J, Sun X, Ortiz A, Barber J, Harris L, et al. Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol. 2012;5:646-57 pubmed 出版商
  125. Magalhaes I, Vudattu N, Ahmed R, Kuhlmann Berenzon S, Ngo Y, Sizemore D, et al. High content cellular immune profiling reveals differences between rhesus monkeys and men. Immunology. 2010;131:128-40 pubmed 出版商
  126. Hunter P, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum. 2010;62:896-907 pubmed 出版商
  127. Brucklacher Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol. 2009;183:5494-501 pubmed 出版商
  128. Koenen H, Smeets R, Vink P, van Rijssen E, Boots A, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood. 2008;112:2340-52 pubmed 出版商
  129. Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Kaibara N, et al. Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2008;67:1299-304 pubmed